Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

(MedPage Today) — ORLANDO — Azacitidine and venetoclax (Venclexta) significantly improved event-free survival (EFS) in newly diagnosed fit adults with acute myeloid leukemia (AML) compared with conventional induction chemotherapy, a phase II…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118890

Author :

Publish date : 2025-12-08 18:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

Many Patients Still Face GP Referral ‘Black Hole’

Odd elements in supernova blast might have implications for alien life

Related Posts

Gun Injuries in Parents Linked to Mental Health Issues in Kids

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

New Stroke Guideline Pushes EVT for Larger Core Strokes, Mobile Stroke Units

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Gun Injuries in Parents Linked to Mental Health Issues in Kids

Psoriatic Disease: QOL Improved With GLP-1 RA Plus Biologic

New Stroke Guideline Pushes EVT for Larger Core Strokes, Mobile Stroke Units

Nearly Half of Americans Expected to Have Obesity in the Next 10 Years

A Call to Consider Patients’ Medication List When Prescribing Cancer Immunotherapy

How to Survive Night Shifts as a Resident

Next DSM Insights; FDA Reviewing Non-Stimulant ADHD Drug; 10M People Microdosing

Viral and Nonviral NICU Infection Rates Diverged During the COVID Pandemic

Categories

Archives